Photo Release: Herbalife Nutrition Thailand Receives Best Practice Award 2020 from the Phra Dabos Foundation

Food and Healthcare Press Releases Wednesday March 4, 2020 15:20
Bangkok--23 Mar--Francom Asia

Herbalife Nutrition, a premier global nutrition company, recently received a Best Practice Award 2020 from the Phra Dabos Foundation for its initiatives that benefit the youth, society and the nation. The distinction, given by Air Chief Marshal Chalit Phukphasuk, Privy Counsellor and Secretary General of Phra Dabos Foundation, to Mr. Suphot Rittipichaiwat, General Manager, Herbalife Nutrition (Thailand) recognizes the company’s quality management strategies, sustainable ethical practices and CSR initiatives.

For more information on Herbalife Nutrition in Thailand, please visit www.Herbalife.co.th our Facebook page or call 02-660-1600.

Latest Press Release

Ansell Urges Global Priority For Supply Of Personal Protective Equipment

Ansell Limited, a global leader in protective solutions, is working with governments and health organizations worldwide to ensure unrestricted personal protective equipment (PPE) manufacture and supply is given top priority during the COVID-19...

Yiling Pharmacy Lianhua Qingwen has been approved by the Thai FDA

On March 31, Shijiazhuang Yiling Pharmaceutical Co., Ltd released a notice that they had received the approval of the modern herbal medicine registration issued by the Food and Drug Administration of Thailand. Lianhua Qingwen Capsule is recognized as in...

EW Nutrition Launches Industry-leading Webinar Series With Topical Antimicrobial Resistance Twin Sessions

Yesterday, German-based company EW Nutrition took a first step toward serving the animal production industry in these challenging times. The in-feed and on-farm solutions company has started a series of topical webinars on challenging issues such as...

Saxenda(R) Demonstrated Improvements in BMI and Body Weight in Adolescents With Obesity

Novo Nordisk today announced that the New England Journal of Medicine published results of a phase 3 trial evaluating the investigational use of Saxenda(R) (liraglutide 3.0 mg) in adolescents (aged 12–<18) with obesity.1 The study was accepted...

Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; Landmark New Partnership with U.S. Department of Health & Human Services; and Commitment to Supply One Billion Vaccines Worldwide for Emergency Pandemic Use

Johnson & Johnson and BARDA Together Commit More than $1 Billion to Novel Coronavirus Vaccine Research and Development; Company Expects to Initiate Phase 1 Human Clinical Studies of Vaccine Candidate at Latest by September 2020 Johnson & Johnson...

Related Topics